PP15 – Does Genetic Testing have a role in Population Health Management?
The world of genetics is constantly evolving, changing the future of medicine and the health of the public. Genetic testing plays a very important role in preventive medicine and population health management. By identifying the risk of actionable diseases, patients are informed and their actions can result in both positive clinical and financial outcomes. This session aims to expand Case Managers’ genetics knowledge and familiarity with the field of genetics from family history collection & interpretation, criteria for genetics evaluation/referral, benefits and limitations of genetic testing, to implications of test results on patient management so they are able to integrate new technologies, genetic testing, and research into medical or clinical practice. We will also be exploring the timeline of prenatal genetics and the current landscape. Currently, three genetic screens are routinely seen within the women’s health space: carrier screening for genetic disorders (cystic fibrosis, spinal muscular atrophy etc…), cell free fetal DNA screening for chromosomal aneuploidies (Trisomies 13,18,21) and inherited cancer screening (BRCA1/2, Lynch syndrome genes, etc…). The landscape of these tests have evolved drastically over the last decade and we will discuss this evolution, the pros and cons of these tests and how to educate on these topics, identify resources for patients, and improve financial and clinical outcomes.